Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.
Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.
Curis Total Payout Yield % Related Terms
Curis Total Payout Yield % Historical Data
* Premium members only.
The historical data trend for Curis's Total Payout Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:CUS1 vs CALC, ICU, TRAW: Total Payout Yield % Comparison
For the Biotechnology subindustry, Curis's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curis Total Payout Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Curis's Total Payout Yield % distribution charts can be found below:
* The bar in red indicates where Curis's Total Payout Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curis (STU:CUS1) has a Total Payout Yield % of -209.84 as of Jul. 07, 2026. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Curis and its competitors.
Is Curis' Total Payout Yield % too high?
Curis' current Total Payout Yield % is -209.84. Overall, Curis has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curis' Total Payout Yield % compare to CALC and ICU?
Curis' Total Payout Yield % of -209.84 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Yield % for a Biotechnology company?
A good Total Payout Yield % depends on the Biotechnology industry context. However, Total Payout Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Yield % mean?
A high Total Payout Yield % can signal that a stock is expensive relative to its fundamentals. Total Payout Yield is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Market Cap. View historical data on Curis and its competitors. Curis's current Total Payout Yield % is -209.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis stock overvalued right now?
Based on GuruFocus' analysis, Curis (STU:CUS1) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.47, compared to a current price of €5.96 — trading 305.4% above its estimated fair value. The current Total Payout Yield % is -209.84. Curis' overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Yield % calculated?
Total Payout Yield % is calculated from a company's financial statements. For Curis (STU:CUS1), the current Total Payout Yield % is -209.84 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Curis (STU:CUS1) Overvalued in 2026?
Based on GuruFocus' analysis, Curis stock appears to be overvalued.
The current stock price of €5.96 is trading 305.4% above its estimated GF Value™ of €1.47.
GuruFocus considers Curis to be Significantly Overvalued.
Key valuation signals for STU:CUS1:
Total Payout Yield %: -209.84
GF Value™: €1.47 vs. price of €5.96 (305.4% above fair value)
No single metric tells the full story. See the STU:CUS1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
50GF Score
Get the complete analysis for STU:CUS1
Total Payout Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:CUS1 has been successfully added to your 
